Palliative treatment in terminally ill elderly patients;Cure palliative nel paziente anziano terminale

Giornale di Gerontologia

Volumn 48, Issue 4, 2000, Pages 222-246

  Venturiero, V ^a   Tarsitani, P ^a   Liperoti, R ^a   Ardito, F ^a   Carbonin, P ^a   Bernabei, R ^a   Gambassi, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; BUPRENORPHINE; CISAPRIDE; CODEINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DIAZEPAM; FENTANYL; GESTAGEN; GLUCOCORTICOID; IBUPROFEN; KETOPROFEN; KETOROLAC; LOPERAMIDE; LORAZEPAM; METHADONE; METOCLOPRAMIDE; MORPHINE; NAPROXEN; OCTREOTIDE; ONDANSETRON; PANCREATIN; PARACETAMOL; PETHIDINE; RANITIDINE; SUCRALFATE; TRAMADOL; UNINDEXED DRUG;

ANOREXIA; CHRONIC PAIN; DIARRHEA; DYSPNEA; HUMAN; MASSAGE; NAUSEA; PALLIATIVE THERAPY; PSYCHOTHERAPY; REVIEW; TERMINALLY ILL PATIENT; VOMITING;

EID: 0033743986     PISSN: 00170305     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (248)

1. Palliative Medicine in the elderly
2. Palliative medicine-a new specialty
3. A controlled trial to improve care of seriously ill hospitalized patients: The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment
4. Treatment of the dying in the acute care hospital: Advanced dementia and metastatic cancer
5. End-of-life measures address changing needs
6. The hard task of improving the quality of care at the end-of-life
7. Prognoses of seriously ill hospitalized patients on the days before death: Implications for patient care and public policy
8. Extent and determinants of error in doctors' prognoses in terminally ill patients: Prospective cohort study
9. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart or liver disease
10. The relative accuracy of the clinical estimation of the duration of life for patients with end-of-life cancer
11. The comprehensive geriatric assessment: When, where, how
12. Do specialist palliative care teams improve outcomes for cancer patients? A systematic literature review
13. Comprehensive geriatric assessment: A meta-analysis of controlled trials
14. Global health care: The role of geriatrician, general practitioner and oncology nurse
15. Comprehensive Assessment of patients in palliative care. A descriptive study utilizing the INTERMED
16. A critical appraisal of the quality of quality-of-life measurements
17. Assessment of health-related quality of life
18. Assessment of the need for palliative care as perceived by individual cancer patients and their families
19. The sickness impact profile: Development and final revision of a health status measure
20. The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection
21. Measuring disease-specific quality of life in clinical trials
22. Assessing the quality of life of the individuals: The SEIQOL with a healthy and a gastroenterology unit population
23. Quality end-of-life care. Patients' perspectives
24. The promise of a good death
25. Measuring quality at the end-of-life
26. Health status versus quality of life in older patients: Does the distinction matter?
27. ABC of palliative care: Principles of palliative care and pain control
28. Pain and its treatment in outpatients with metastatic disease
29. Pain: An overview
30. Pain: The neurobiology of pain
31. Management of cancer pain in older patients
32. Assessment of pain during medical procedures: A comparison of three scales
33. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases
34. The McGill Pain Questionnaire: Major properties and scoring methods
35. Pain in cognitively impaired nursing home patients
36. The nature of suffering and the goals of medicine
37. Inplementing guide lines for cancer pain management: Results of randomized control clinical trial
38. Validation of WHO guidelines for cancer pain relief: A 10-year prospective study
39. Validation of WHO guidelines for cancer pain relief during the last days and hours of life
40. Epidural clonidine analgesia for intractable cancer pain: The Epidural Clonidine Study Group
41. Neurolytic celiac plexus block for treatment of cancer pain: A meta-analysis
42. Management of pain in elderly patients with cancer
43. Pain syndromes in patients with cancer and HIV/AIDS
44. Management of cancer pain
45. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional non steroidal antiinflammatory drugs, with less gastroitestinal toxicity?
46. Meloxicam
47. Clinical experience with cyclooxygenase-2 inhibitors
48. Nimesulide and cox-2 inhibitors
49. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs
50. Tramadol: A new centrally acting analgesic
51. Current pharmacotherapy of chronic pain
52. Opioid rotation for cancer pain: Rationale and clinical aspects
53. Transdermal fentanyl versus suatained-release oral morphine in cancer pain: Preference, efficacy, and quality of life
54. Intraspinal opioid therapy
55. Age related morphine kinetics
56. Switching from morphine to oral methadone in treating cancer pain. What is the equianalgesic dose ratio?
57. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer
58. Dextroamphetamine with morphine for the treatment of post-operative pain
59. A randomized, cross-over evaluation of methylphenidate in cancer patients receiving strong narcotics
60. Nausea and Vomiting in patients with cancer
61. Inappropriate use of naloxone in cancer patients with pain
62. Adjuvant analgesics in pain management
63. The management of cancer pain
64. Corticosteroids as adjuvant analgesics
65. A systematic review of antidepressants in neuropathic pain
66. Anticonvulsant drugs for management of pain: A systematic review
67. Gabapentin for treatment of pain and tremor: A large case series
68. The neuroleptics as adjuvant analgesics
69. American society of clinical oncology guideline on the role of bisphosphonates in breast cancer
70. ABC of palliative care: Nausea, vomiting and intestinal obstruction
71. Dying from heart disease
72. Nausea and vomiting in advanced cancer
73. Common symptoms in advanced cancer
74. Neuropharmacology of emesis and its relevance to anti-emetic therapy: Consensus and controversies
75. Palliation of nausea and vomiting
76. Antiemetic therapy in adults with terminal disease: A brief review
77. Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the Perugia Consensus Conference
78. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction
79. Role of octreotide, scopolamine, butilbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes. A prospective randomized trial
80. ABC of palliative care: Constipation and diarrhea
81. The assessment of constipation in terminal cancer patients admitted to a palliative care unit: A retrospective review
82. Constipation: Assessment and management in an instituzionalized elderly population
83. How effective is non laxative treatment of constipation?
84. Constipation in advanced cancer patients
85. Constipation and diarrhea
86. Antidiarrheal agents for the management of the treatment-related diarrhea in cancer patients
87. Management of cancer treatment-related diarrhea. Issues and therapeutic strategies
88. Multicenter double-blind clinical trial comparing sucralfate vs placebo in diarrhea secondary to pelvic irradiation
89. Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A north central cancer treatment group phase III double-blind placebo-controlled trial
90. Aspirin in radiation-induced diarrhoea
91. A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome
92. Review article: Practical management of the short bowel
93. Oral problems in advanced cancer
94. Xerostomia: Diagnosis and management
95. Xerostomia: Aetiology and management in cancer patients
96. Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients
97. Sucralfate suspension as a treatment of recurrent aphthous stomatitis
98. Topical medications for orofacial neuropathic pain: I review
99. Benzydamine Hydrochoride (Tantum) in the management of oral inflammatory conditions
100. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or fentanyl for the treatment of oral mucositis pain following bone marrow transplantation
101. Fluconazole versus Nystatin in the treatment of oral candidosis
102. Management of dyspnea in advanced cancer patients
103. Distinguishable sensations of breathlessness induced in normal volunteers
104. Dyspnea: A study of measurement instruments for the assessments of dyspnea and their application for patients with advanced cancer
105. Dyspnea: Assessment and treatment
106. Assessment of dyspnea in advanced cancer patients
107. Dyspnea: Pathophysiology and assessment
108. Non pharmacological intervention for breathlessness in lung cancer
109. Palliative management of dyspnea in advanced cancer
110. Effects of morphine on the dyspnea of terminal cancer patients
111. Subcutaneous morphine for dyspnea in cancer patients
112. Continuous intravenous infusion of morphine for severe dyspnea
113. Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease
114. Nebulized morphine in the palliation of dyspnea
115. Fentanyl for dyspnea relief
116. Effects of oxygen on dyspnea in hypoxaemic terminal-cancer patients
117. Management of specific symptom complexes in patients receiving palliative care
118. Diagnosis and Nd-YAG laser treatment of unsuspected malignant tracheal obstruction
119. Temporary tracheobronchial stenting in malignant stenosis
120. Symptom control in advanced cancer: Important drugs and routes of administration
121. Management of dyspnea and cough in patients with cancer
122. Appropriate use of antitussive and protussive. A practical review
123. Airway anaesthesia and the cough reflex
124. Preventing and managing pressure sores in palliative care
125. The importance of dietary protein in healing pressure ulcers
126. Support surfaces and their use in the prevention and treatment of pressure ulcers
127. Pressure sores and pressure decreasing mattresses: Controlled clinical trial
128. Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressure ulcers
129. American Cancer Society Lymphedema Workshop. Workshop III: Diagnosis and management of lymphedema
130. Common complications of advanced cancer
131. Therapy approaches for lymphedema
132. Outcomes and outcome indicators of lynphedema treatment
133. ABC of palliative care: Anorexia, cachexia, and nutrition
134. The syndrome of anorexia-cachexia
135. Cancer anorexia-cachexia syndrome: Are neuropeptides the key?
136. Clinical efficacy of nutritional support in patients with cancer
137. Effect of methyl prednisolone sodium succinate on quality of life in preterminal cancer patients: A placebo-controlled multicenter study: The Methilprednisolone Preterminal Cancer Study Group
138. Action of oral methyl prednisolone in terminal cancer patients: A prospective randomized double-blind study
139. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia-cachexia
140. A double-blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia
141. The use of metoclopramide in anorexia due to the cancer-associated dyspepsia syndrome (CADS)
142. Beneficial effects of an anabolic steroid during citotoxic chemotherapy for metastatic cancer
143. Effects of human growth hormone in men over sixty years old
144. Increased mortality associated with growth hormone treatment in critically ill adults
145. Neurocognitive dysfunction in cancer patients
146. Depression and the cancer patients
147. Psychosocial aspects of palliative care
148. Cancer and depression
149. Depression in cancer patients: A literature review
150. Depression in patients with lung cancer: Prevalence and risk factors derived from quality of life data
151. Depression and suicide in patients with cancer
152. Influence of age on psychological adjustment to cancer
153. Depression scales for the elderly: GDS
154. Screening for depression in primary care clinics: The CES-D and the BDI
155. Development of a rating scale for primary depressive illness
156. Concurrent psychoterapy and pharmacotherapy in the treatment of depression and anxiety in cancer patients
157. Diagnosis and treatment of depression in cancer patients
158. Essentials of psychotherapeutic interventions for cancer patients
159. Improving the quality and quantity of life among patients with cancer: A review of the effectiveness of group psychotherapy
160. Trimipramine in physical illness with depression
161. Efficacy and safety of mianserin in treatment of depression of woman with cancer
162. The effect of fluoxetine on anxiety and depression symptoms in cancer patients
163. The outcome of antidepressant use in the medically ill
164. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer
165. Pharmacokinetic considerations of antidepressants use in the elderly
166. Treatment guidelines for geriatric mood disorders
167. New antidepressants for old people?
168. Anxiety disorders in late life
169. Palliative care: An update on 'terminal restelssness'
170. The last few days
171. Midazolam (Dormicum) in terminal anxiety and agitation. The last choice alternative in palliative care
172. Delirium in elderly patients: Evaluation and management
173. Precipitating factors for delirium in hospitalized elderly persons: Predictive model and interrelationship with baseline vulnerability
174. A predictive model of delirium in hospitalized elderly medical patients based on admission characteristics
175. Occurrence, causes, and outcome of delirium in patients with advanced cancer. A prospective study
176. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
177. A multicomponent intervention to prevent delirium in hospitalized older patients
178. Delirium in the older person with cancer
179. Delirium in cancer patients
180. A retrospective study of the psychiatric management and outcomes of delirium in the cancer patient
181. Progress toward guidelines for the management of fatigue
182. A critical appraisal of the research literature investigating fatigue in the individual with cancer
183. Evaluation of the elderly patient with weakness: An evidence based approach
184. Cancer-related fatigue: Guidelines for evaluation and management
185. The Groopman article reviewed
186. The Multidimensional Fatigue Inventory (MF1) psychometric qualities of an instrument to assess fatigue
187. Insuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system
188. The development of an instrument to measure the subjective dimension of fatigue
189. Measurement of fatigue in cancer patients: Development and validation of the Fatigue Symptom Inventory
190. Fatigue
191. Aerobic exercise as therapy for cancer fatigue
192. Promoting functional capacity of cancer patients
193. Patterns of exercise and fatigue in physically active cancer survivors
194. Factors influencing quality of life in cancer patients: Anemia and fatigue
195. Identifying patients at risk for, and treatment of major psychiatric complications of cancer
196. Fatigue, depression and quality of life in cancer patients: How are they related?
197. Correlation between physical performance and fatigue in cancer patients
198. Strategies for the review of transfusion practices
199. Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer
200. Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer
201. Treatment of depression in the medically ill elderly with methylphenidate
202. A different look at corticosteroids
203. Treatment of metastatic prostatic cancer with low-dose prednisone: Evaluation of pain and quality of life as pragmatic indices of response
204. Care of the family when the patient is dying
205. Psychosocial care in advanced patients
206. Taking families seriously
207. ABC of palliative care: The carers
208. Caregiving as a risk factor for mortality: The Caregiver Health Effects Study
209. Caregiving spouses - Physical and mental health in perspectives
210. Death from cancer at home: The carer's perspectives
211. Loss, grief, and bereavement in family members of cancer patients
212. Predictors of bereavement outcome for family carers of cancer patients
213. ABC of palliative care: Bereavement
214. Changes in physicians' attitudes toward telling the cancer patients
215. Offering truth - One ethical approach to the uniformed cancer patient
216. Patient-physician communication: An emerging partnership
217. How should doctors communicate the diagnosis of cancer to patients?
218. Cancer information: A cost-effective intervention
219. Palliative treatments of last resort: Choosing the least harmful alternative
220. Spirituality and well-being in terminally ill adults
221. The physician's responsibility toward hopelessly ill patients
222. The family caregiver of the older cancer patient
223. End-of-life care after termination of Support
224. Balance of care for the dying between hospitals and the community: Perceptions of general practitioners, hospital consultants, community nurse and relatives
225. Randomized controlled trial of effects of coordinating care for terminally ill cancer patients
226. A randomized controlled trial of the cost-effectiveness of a district co-ordinating service for terminally ill cancer patients
227. Hospice role in alleviating the emotional stress of terminal patients and their families
228. Cost-effectiveness of Veterans Administration hospital-based home care: A randomized clinical trial
229. A randomized trial of the cost effectiveness of VA hospital-based home care for the terminally ill
230. Systematic implementation of an advanced directive program in nursing homes. A randomized controlled trial
231. Impact of home care on hospital days: A metanalysis
232. Preclinical palliative medicine education at the Medical Oncology Department of Wisconsin
233. Housestaff training in cancer pain education
234. Improving palliative care
235. Can clinical interventions change care at the end of life?